4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-020988
Options or other derivatives
- Chief Financial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reed Joshua Chief Financial Officer | 2018-07-30 | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | D | ||
Loading xslF345X03/doc4.xml…